59 studies found for:    "Berger disease"
Show Display Options
Rank Status Study
1 Completed Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Conditions: Glomerulonephritis, IGA;   Nephropathy, IGA;   IGA Nephropathy
Interventions: Drug: ACE inhibitor + statin;   Drug: Sirolimus (study drug)+ACE inhibitor + statin
2 Completed Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: ENALAPRIL VALSARTAN METHYLPREDNISONE
3 Completed Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Procedure: gene transcription and cytometry
4 Completed A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Conditions: Glomerulonephritis;   IGA Nephropathy
Interventions: Drug: Valsartan;   Drug: Probucol;   Drug: Placebo
5 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
6 Completed
Has Results
A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: allopurinol;   Other: continue their usual therapy
7 Completed Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Mycophenolate mofetil
8 Recruiting Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: prednisone plus cyclophosphamide;   Drug: Prednisone alone
9 Terminated Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Conditions: IGA Nephropathy;   Proteinuria
Intervention: Biological: OPL-CCL2-LPM
10 Not yet recruiting BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: Blisibimod;   Drug: Placebo
11 Completed A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
Condition: IgA Nephropathy
Intervention:
12 Completed An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
Condition: IgA Nephropathy
Intervention:
13 Recruiting Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Study)
Condition: IgA Glomerulonephritis
Interventions: Drug: methylprednisolone;   Drug: Placebo,
14 Recruiting BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
Condition: IgA Nephropathy
Interventions: Drug: Blisibimod;   Drug: Placebo
15 Recruiting Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
Condition: IgA Nephropathy
Interventions: Drug: irbesartan;   Drug: methylprednisolone (MP) or prednisone (pred);   Drug: mycophenolate mofetil (MMF)
16 Active, not recruiting The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
Condition: Primary IgA Nephropathy
Interventions: Drug: NEFECON;   Other: Placebo
17 Recruiting Rituximab in Progressive IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: Intravenous Rituximab;   Drug: ACE/ARB
18 Completed Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
Condition: IgA Nephropathy
Intervention: Drug: Mycophenolate Mofetil (MMF)
19 Active, not recruiting Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: supportive therapy with: ACE-inhibitor / ARB / Statin;   Drug: supportive and immunosuppressive therapy
20 Unknown  Diet Intervention in Food Sensitive Patients With IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Dietary Supplement: Tailored diet;   Dietary Supplement: Low antigen content diet

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years